James Conlin Pace
Editor in Chief
Uwe Blecker, MD
Professor of Pediatrics

University of Mississippi Medical Center
N State St, Jackson, USA
Phone: (601) 984-5295
E-Mail: ublecker@umc.edu

Education

Doctor of Medicine (M.D.) 1990  Free University of Brussels: magna cum laude.
Bachelor in (Medical) Sciences (B.S.). 1986 Free University of Brussels

Postdoctoral Training

Residency 

 7/90 - 6/93

 Resident in Pediatrics

Academic Children's Hospital; Free University of Brussels; Brussels Belgium

Fellowship

7/93 - 6/94

Pediatric Gastroenterology and Nutrition

Hahnemann University Hospital; Philadelphia, PA

Fellowship

7/94 - 11/94 

Pediatric  Gastroenterology , Hepatology and Nutrition 

Wyler Children's Hospital; University of Chicago; Chicago, IL

Fellowship

12/94 - 8/95

Pediatric Gastroenterology and Nutrition

Academic Children's Hospital; Free University of Brussels; Brussels - Belgium.

 

Profile

After receiving the B.S. in medical sciences in 1986, Dr. Uwe Blecker then earned the M.D. magna cum laude from Free University of Brussels, Belgium in 1990.
He then completed a pediatric residency from 1990-93 at Academic Children’s Hospital in Brussels. From 1993-94, he was a fellow in pediatric gastroenterology and nutrition at Hahnemann University Hospital in Philadelphia, Penn. In 1994, he continued his fellowship in pediatric gastroenterology, hepatology and nutrition at Wyler Children’s Hospital at the University of Chicago. In 1994, he returned to Academic Children’s Hospital to complete his fellowship in pediatric gastroenterology and nutrition.
 
Blecker served as director of the Sleep Lab and Pediatric Gastroenterology Admission Unit at the Free University of Brussels from 1995-96 before joining Louisiana State University School of Medicine as associate professor of pediatrics and medical director of the LSU Medical Center Pediatric Weight Management Program. In 1998, he joined the faculty at Thomas Jefferson University as associate professor of pediatrics and director of Nutrition Support Services at Alfred I. DuPont Hospital for Children in Philadelphia, Penn. In 2000, he became professor of pediatrics and chief of the Division of Pediatric Gastroenterology and Nutrition at The University of Arizona Health Sciences Center in Tucson. In 2001, he joined the staff of St. Christopher’s Hospital for Children and Drexel University in Philadelphia as professor of pediatrics and chief of the Division of Gastroenterology, Hepatology and Nutrition. He returned to Tucson in 2002 as director of the Pediatrics and Gastroenterology program at Tucson Medical Center and director of Pediatric Gastroenterology, P.C. He became professor of  pediatrics and chief of the Division of Pediatric Gastroenterology and Nutrition at West Virginia University Health Sciences Center in 2008. Prior to joining the Medical Center, he was a Pediatric gastroenterologist at Centre Hospitalier Emile Mayrisch in Luxembourg from 2009 to 2014.

He is board-certified in pediatrics and pediatric gastroenterology and nutrition.  Blecker has served as co-principal investigator or principal investigator for numerous studies and is the author of more than 100 articles in peer-reviewed publications, four books, six book chapters and nearly 300 communications at national and international meetings.

Research Interest

  • Pediatric Gastroenterology

Research Overview

Title: A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of Humira® (Adalimumab) in Pediatric Patients with Moderately to Severely Active Crohn’s Disease.
Funding Agency: Mapi
P.I.: Uwe Blecker, M.D.
Dates: 11/2014 – present

Grants

  • 1. Title: Double-blind, randomized, placebo-controlled clinical trial for Trimebutine (DEBRIDAT) in functional (non-organic) intestinal disturbances in children.

    • Funding Agency: JOUVEINAL Laboratories; Fresnes (Paris) - France. Protocol : JO 1061 SB CLI 91001.
    P.I.: Yvan Vandenplas, M.D., Ph.D.
    Co-P.I.: Uwe Blecker, M.D.
    Dates: 1995-1996
    Total Amount: FRF 150,000

  • 2. Title: Helicobacter pylori in childhood.

    • Funding Agency: Nutricia
    P.I. Uwe Blecker, M.D.
    Dates 1996
    Total Amount: BEF 250,000

  • 3. Title: A multi-site investigation of seropositivity for Helicobacter pylori in children in the United States.

    • Funding Agency: N/A
    P.I.: John N. Udall, Jr., M.D., Ph.D.
    Co-P.I.: Uwe Blecker, M.D.
    Dates: 1996-1998
    Total Amount: $20,000

  • 4. Title: The use of Protein Sparing Modified Fast (PSMF) in the outpatient treatment of obesity in children and adolescents.

    • Funding Agency: LSU Foundation
    P.I.: Robert M. Suskind, M.D.
    Co-investigator: Uwe Blecker, M.D.
    Dates: 1997-1998
    Total Amount: $70,000

  • 5. Title: Supplemental genetic study with the use of Protein Sparing Modified Fast (PSMF) in the outpatient treatment of obesity in children and adolescents.

    • Funding Agency: LSU Foundation
    P.I.: Robert M. Suskind, M.D.
    Co-investigator: Uwe Blecker, M.D.
    Dates: 1997-1998
    Total Amount: $70,000

  • 6. Title: Pediatric weight management program implementation.

    • Funding Agency: West Jefferson Medical Center
    P.I.: Uwe Blecker, M.D.
    Co-P.I. Melinda Sothern, Ph.D.
    Dates: 10/97 – 9/98 (renewed for 10/98-9/99)
    Amount: $120,000

  • 7. Title: Risk factors and gastric disease in pediatric H. pylori.

    • Funding Agency: NIH RFA DK-97-003. Application Number: 1 RO1 DK53708-01.
    P.I.: Benjamin D. Gold, M.D.
    Co-P.I. Uwe Blecker, M.D.
    Dates: 1997-2002
    Total Amount: $1,134,255

  • 8. Title: The additive effects of cognitive-behavioral family intervention and standard pediatric care in the treatment of recurrent abdominal pain in children: are better outcomes less expensive?

    • Funding Agency: Nemours Research Programs
    P.I.: Paul Robins, Ph.D.
    Co-investigator: Uwe Blecker, M.D.
    Dates: 10/1/97 – 9/30/00
    Total Amount: $13,850

  • 9. Title: Acute pancreatitis after posterior spinal fusion.

    • Funding Agency: Nemours Research Programs
    P.I.: Devendra I. Mehta, MBBS, MSc
    Co-investigator: Uwe Blecker, M.D.
    Dates: 11/1/99 – 10/31/01
    Total Amount: $111,070

  • 10. Title: An eight-week, randomized, double-blind, placebo-controlled study of Alosetron in non-constipated adolescents with Irritable Bowel Syndrome.

    • Funding Agency: Glaxo Wellcome. Clinical Trial No. S3B30015
    P.I.: Uwe Blecker, M.D.
    Dates: 12/1/99 – 1/30/00
    Amount: $23,920

  • 11. Title: A sixteen-week, open-label, safety study of Alosetron in non-constipated adolescents with Irritable Bowel Syndrome.

    • Funding Agency: Glaxo Wellcome. Clinical Trial No. S3B30019
    P.I.: Uwe Blecker, M.D.
    Dates: 12/1/99 – 1/20/00
    Amount: $18,010

  • 12. Title: Safety and Efficacy of Pentavalent (G1, G2, G3, G4, and P1) Human-Bovine Reassortant Rotavirus Vaccine in Healthy Infants.

    • Funding Agency: Merck
    P.I.: Uwe Blecker, M.D.
    Dates: 2001 - 2002
    Amount: $210,566

  • 13. Title: Visiting Professorship in Pediatric Gastroenterology.

    • Funding Agency: St. Christopher’s Foundation for Children.
    P.I.: Uwe Blecker, M.D.
    Dates: 2002
    Amount: $3,500

  • 14. Title: A Multi-Center, Randomized, Double-Blind Study of the Safety, Tolerability and Clinical Outcomes of 2 Doses (20 and 40 mg) of Oral Pantoprazole in Children (12-16 Years Old) With Symptomatic GERD.

    • Funding Agency: Wyeth Research
    P.I.: Uwe Blecker, M.D.
    Dates: 11/2003 – 6/2004
    Amount: $31,696

  • 15. Title: A Multicenter, Double-Blind, Parallel Group Study to Evaluate Short-term Safety and Efficacy and Long-term Maintenance of Two Dose Levels of Rabeprazole Sodium Delayed Release Pediatric Bead Formulation in 1 to 11 Year Old Pediatric Subjects with Endoscopically Proven GERD (Protocol Number: RABGRD3003).

    • Funding Agency: Johnson & Johnson
    P.I.: Uwe Blecker, M.D.
    Dates: 9/2008 - 6/2010

  • 16. Title: A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Withdrawal Study to Evaluate the Safety and Efficay of Rabeprazole Delayed Release in 1 to 11 Month Old Pediatric Subjects with Symptomatic/Erosive Gastroesophageal Reflux Disease (Protocol Number: RABGRD3004).

    • Funding Agency: Johnson & Johnson
    P.I.: Uwe Blecker, M.D.

    Dates: 9/2008 – 6/2010.

     

     

    Professional Activities

    • The University of Mississippi Medical Center (7/2014 - present) Professor of Pediatrics Attending Pediatric Gastroenterologist
    • Centre Hospitalier Emile Mayrich (7/2009 - 6/2014) Attending Pediatric Gastroenterologist
    • West Virginia University Health Sciences Center (5/08 - 6/10) Professor of Pediatrics
    • Pediatric Gastroenterology, P.C. / Tucson Medical Center (4/02 - 4/08) Director - Pediatrics and Gastroenterology Program Tucson Medical Center Director
    • St. Christopher’s Hospital for Children / Drexel University (3/01 - 4/02) Professor of Pediatrics
    • The University of Arizona Health Sciences Center (8/00 - 2/01) Professor of Pediatrics
    • Louisiana State University School of Medicine (7/96 - 7/98) Associate Professor of Pediatrics
    • Free University of Brussels (9/95 - 6/96)  Director - Sleep Lab and Pediatric Gastroenterology Admission Unit

    Membership In Professional Societies And Associations

    • North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN)   (1993-present)
    • American Academy of Pediatrics (1993-present)
    • American Academy of Pediatrics - Mississippi Chapter (2014-present)
    • American Academy of Pediatrics - Section on Gastroenterology, Hepatology & Nutrition (2014-Present)
    • American Academy of Pediatrics - Section on International Medical Graduates (2014-present)
    • Central Medical Society (2014-present)
    • Mississippi Medical Society (2014-present)
    • Arizona Medical Association (2002-2004)
    • American Academy of Pediatrics - Section on Gastroenterology & Nutrition (2001-present)
    • American Academy of Pediatrics - Arizona Chapter (2002-2009)
    • American Gastroenterological Association (AGA) (1993-2009)
    • American Society for Parenteral & Enteral Nutrition (ASPEN) (1996-2000)
    • Crohn’s & Colitis Foundation of America (CCFA) (1998-2009)
    • American Medical Association (1993-1995; 1998-2000)
    • Medical Society of Delaware (1998-2000)
    • New Castle County Medical Society (1998-2000)
    • Southern Society for Pediatric Research (SSPR) (1996-1998)
    • New Orleans Gut Club (1996-1998)
    • Greater New Orleans Pediatric Society (GNOPS) (1996-1999)
    • World Trade Center of New Orleans (1997-1999)
    • Belgian Group of Pediatric Gastroenterology and Nutrition (1993-1996)
    • Belgian Pediatric Society (1990-1996)
    • Flemish Pediatric Society (1990-1996)
    • Helicobacter pylori Belgian Contact Group (1995-1997)
    • American College of Gastroenterology (1993-1995)
    • Pennsylvania Medical Society (1993-1995)
    • Philadelphia County Medical Society (1993-1995)
    • Gastroenterology Research Group (1994-1995)

    Administrative Experience

    1. Director, Pediatric Inflammatory Bowel Disease Center, The University of Mississippi Medical Center.
    2. Director, Pediatric Gastroenterology Fellowship Program, The University of Mississippi Medical Center.
    3. Chief, Division of Pediatric Gastroenterology and Nutrition, West Virginia University Health Sciences Center.
    4. Director – Pediatrics and Gastroenterology Program – Tucson Medical Center.
    5. Director – Pediatric Gastroenterology, P.C.
    6. Medical Director, Gastroenterology Lab – Tucson Medical Center.
    7. Chief, Division of Gastroenterology, Hepatology and Nutrition, St. Christopher’s Hospital for Children / Drexel University.
    8. Director, Pediatric Liver Transplant Program, St. Christopher’s Hospital for Children / Drexel University.
    9. Director of Nutrition, St. Christopher’s Hospital for Children / Drexel University.
    10. Director, Pediatric GI Fellowship Training Program, St. Christopher’s Hospital for Children / Drexel University.
    11. Chief, Division of Pediatric Gastroenterology and Nutrition, The University of Arizona Health Sciences Center
    12. Director, Nutrition Support Services, Thomas Jefferson University / Alfred I. DuPont Hospital for Children.
    13. Director, Pediatric Gastroenterology Fellowship Training Program, Thomas Jefferson University / Alfred I. DuPont Hospital for Children.
    14. Chairman, Nutrition Support Committee, Thomas Jefferson University / Alfred I. DuPont Hospital for Children.
    15. Medical Director – L.S.U. Medical Center Pediatric Weight Management Program, Louisiana State University School of Medicine.
    16. Director - Sleep Lab and Pediatric Gastroenterology Admission Unit, Free University of Brussels.
    17. Chair – Oral Abstract Session “Peptic Ulcer Disease and Helicobacter pylori II”. World Congress of Pediatric Gastroenterology and Nutrition (8/2000).

    Honors and Awards

    Awards

    1. 2006 America’s Top Pediatricians
    2. 2004-2005 America’s Top Pediatricians
    3. American Medical Association Physician’s Recognition Award (01/05 – 12/07)
    4. American Medical Association Physician’s Recognition Award (11/00 – 11/03)
    5. Department of the Week. St. Christopher’s Hospital for Children (3/02).
    6. Who’s Who Among Students in American Universities and Colleges. One of 71 students nominated by the University of Baltimore (1/2001).
    7. American Medical Association Physician’s Recognition Award (12/98 – 1/02)
    8. Recipient of the Nutricia Research in Pediatric Gastroenterology and Nutrition (R.P.G.N.) Award (11/96)
    9. Astra Travel Award to the IX International Workshop on Gastroduodenal Pathology and Helicobacter pylori. Copenhagen (Denmark) October 16-19, 1996
    10. Louisiana State University Medical Center Pediatric Resident Sophie Lanciers, working with Dr. Blecker, was awarded the Southern Gut Club’s Resident Research Award (9/96)
    11. Fellow Travel Award. The VIIth Workshop on gastroduodenal pathology and Helicobacter pylori. Houston, TX (U.S.A.) September 30 -October 1, 1994
    12. Recipient of the 8th Scholarship of the Johnny Genna Foundation for the Study of Pediatric Liver Disease (9/94)
    13. Biolab Travel Award. VIth Workshop on Gastroduodenal Pathology and Helicobacter pylori. Brussels (Belgium) September 21-25, 1993

     

    Publications

    Books:

    1. Blecker U.Helicobacter pylori. Dissertation.com,1999.SBN 1-58112-078-8.
    2. Lanciers S, Blecker U. Behandeling van hypertensie in de anesthesie. Universal Publishers, 1999. ISBN 1-58112-778-2.
    3. Blecker U. Pediatric Helicobacter pylori infection. Universal Publishers, 1999. ISBN 1-58112-781-2.
    4. Blecker U. Helicobacter pylori infection in childhood. Dissertation.com, 1999. ISBN 1-58112- 073-7.

    Book chapters:

    1. Gold BD, Blecker U. Gastritis and ulcers in children. In: Pediatric Gastrointestinal Disease: Pathophysiology, Diagnosis, and Management. R. Wyllie and J.S. Hyams (eds). W.B. Saunders Company, Philadelphia 1999, pp. 221-243.
    2. Sothern MS, Blecker U, Suskind RM. Recent advances in the treatment of childhood obesity. In: Pediatric Nutritional Challenges: From Undernutrition to Overnutrition. Report of the 28th Ross Roundtable on Critical Approaches to Common Pediatric Problems 1997, pp. 65-79.
    3. Blecker U. The role of Helicobacter pylori infection in gastrointestinal disease in children. In: Helicobacter pylori Infection: Basic Principles and Clinical Practice. X.G. Fan and H.X. Xia (eds) Hunan Science & Technology Press, 1997, pp. 252-258.
    4. Blecker U. Gastroduodenal diseases in children. In: Helicobacter pylori Infection: Basic Principles and Clinical Practice. X.G. Fan and H.X. Xia (eds) Hunan Science & Technology Press, 1997, pp.115-125.
    5. Blecker U. Gastroenterology & Nutrition. In: Pediatric Review Program. A comprehensive certification and recertification study guide. R.W. Steele and M. Marks (eds). Clinical Communications Inc. 1998.
    6. Blecker U, Franckx-Goossens A, Lauwers S, Vandenplas Y. Helicobacter pylori infection in  children. In: H. pylori and Gastroduodenal Pathology. Pajares JM, Pena AS, Malfertheiner P (eds). Berlin, New York; Springer-Verlag, 1993, pp. 259-262.

    Articles

    1. Blecker U,Lanciers S, Gilles J.Comparison of 24-hour and 48-hour esophageal pH-monitoring in children (in preparation).
    2. Blecker U, Lanciers S,Gilles J.Efficacy and tolerability of the catheter-free BRAVO® esophageal pH-monitoring system in children (in preparation).
    3. Blecker U. Eosinophilic Esophagitis. 352 Magazine 2009;40:42.
    4. Blecker U. Celiac Disease. 352 Magazines 2009; 33:39.
    5. Nield LS, Blecker U.Fecal Incontinence in Children. British Medical Journal Best Practice (onlineedition).
    6. Blecker U.Usan cápsula de video para hacer Endoscopía. Buena Salud 2007; ano 9:No. 80.
    7. Blecker U.Endoscopía con cápsula de video (PillcamTM). Revista Mujer December 2006:No. 96
    8. Tsou VM, et al, Blecker U, et al. Multicenter, Randomized, Double-Blind Study Comparing 20 and 40 mg of Pantoprazole for Symptom Relief in Adolescents (12 to 16 Years of Age) with Gastroesophageal Reflux Disease (GERD). Clin Pediatr 2006;45:741-749.
    9. Mehta ND, Shah HR, Patel R, Glutting J, Blecker U, Mehta DI. Eating and mealtime problems in children in USA and UK: A cross-cultural study. Int J Pediatr 2003;18:217-222.
    10. de Chadarévian JP, Dunn S, Malatack JJ, Gangula A, Blecker U, Punnett HH. Chromosome rearrangement with no detectable gene mutation in familial adenomatous polyposis and hepatocellular neoplasia. Pediatr Dev Pathol 2002;5:69-75.
    11. Sothern MS, Loftin M, Blecker U, Udall JN, Jr. Impact of significant weight loss on maximal oxygen uptake in obese children and adolecents. J Invest Med 2000;48:411-416.
    12. Sothern MS, Suskind RM, Vargas A, Udall JN, Jr., Blecker U. Weight loss and growth velocity in obese youth after very low calorie diet, exercise and behavior modification. Acta Paediatr 2000; 89:1036-1043.
    13. Sothern MS, Loftin JM, Udall JN, Suskind RM, Ewing TL, Tang SC, Blecker U. Safety, feasibility and efficacy of resistance training program in preadolescent obese children. Am J Med Sci 2000;319:370-375.
    14. Taylor DR, Tung JY, Baffa JM, Shaffer SE, Blecker, U. Gastric pneumatosis following cardiac surgery. Eur J Pediatr 2000;159:553-554.
    15. Brown R, Sothern M, Suskind R, Udall J, Blecker U. Racial differences in the lipid profiles of obese children and adolescents before and after significant weight loss.Clin Pediatr 2000;39:427-431.
    16. Suskind RM, Blecker U, Udall JN Jr., von Almen TK, Schumacher HD, Carlisle L, Sothern MS. Recent advances in the treatment of childhood obesity. Pediatric Diabetes 2000;1:23-33.
    17. Taylor DR, Tung JY, Baffa JM, Shaffer SE, Blecker, U. Gastric pneumatosis: a case report and review of the literature. Int Pediatr 2000;15:117-120.
    18. Sothern MS, Despinasse B, Brown R, Suskind RM, Udall JN, Blecker U. Lipid profiles of obese children and adolescents before and after significant weight loss: differences according to sex. S Med J 2000;93:278-282.
    19. Blecker U, Mehta DI, Davis R, Sothern MS, Suskind R. Nutritional problems in patients who have chronic disease. Pediatr Rev 2000;21:29-32.
    20. Blecker U, Gold BD. Gastritis y úlcera péptica en pediatría. Pediatr Integral 1999;4:86-100.
    21. Blecker U,Mehta DI, Davis R, Sothern MS, Suskind RM. Fat-soluble vitamin deficiencies.Pediatr Rev 1999;20:394-395.
    22. Blecker U, Sothern MS, Suskind R. Iron fortified infant formulas. Pediatr Rev 1999;20:359.
    23. Sothern  MS,  Loftin  M,  Suskind  RM,  Udall  JN,  Jr,  Blecker  U.Physiologic  function  and childhood obesity. Int Pediatr 1999;14:135-139.
    24. Lanciers S, Despinasse B, Mehta DI, Blecker U. Increased susceptibility to Helicobacter pylori infection in pregnancy. Inf Dis Obstet Gynecol 1999;7:195-198.
    25. Blecker U, Mehta DI, Gold BD. Pediatric gastritis and peptic ulcer disease: a review. Ind J Pediatr 1999;66:31-39.
    26. Sothern MS, von Almen TK,Schumacher HD, Suskind RM, Blecker U. A multidisciplinary approach to the treatment of childhood obesity.Del Med J 1999;71:255-261.
    27. Udall JN, Jr., Hempe J, Schmidt-Sommerfeld E, Scheer WD, Mannick EE, Blecker U, Correa H. Longitudinal  analysis  of  plasma  Cytomegalovirus  Deoxyribonucleic  Acid inboy withCrohn’s disease and Cytomegalovirus gastroenteritis. J Pediatr Gastroenterol Nutr 1999;28: 502-505.
    28. Escobar O, Mizuma H, Sothern MS, Blecker U, Udall JN, Suskind RM, Hilton C, Vargas A. Hepatic insulin clearance increases after natural weight loss in obese children and adolescents. Am J Med Sci 1999;317:282-286.
    29. Blecker  U,  Sothern  MS,  Udall  JN.  El  papel  de  la  infección  por  Helicobacter  pylori  en  la enfermedad gastrointestinal infantil. Pediatr Integral 1999;3:475-485.
    30. Blecker U, Gold BD. Gastritis and peptic ulcer disease in childhood. Eur J Pediatr 1999;158: 541-546. Sothern MS, Loftin M, Suskind RM, Udall JN, Jr, Blecker U. The impact of significant weight loss on resting energy expenditure in obese youth. J Invest Med 1999;47:222-226.
    31. Sothern MS, Loftin JM, Suskind RM, Ewing TL, Tang SC, Blecker U. The inclusion of resistance exercise in a multi-disciplinary outpatient treatment program for preadolescent obese children. S Med J 1999;92:585-592.
    32. Sothern MS, Hunter S, Suskind RM, Brown R, Udall JN, Jr, Blecker U. Motivating the obese child to move: Exercise and the social cognitive theory. S Med J 1999;92:577-584.
    33. Sothern MS, Loftin M, Udall JN, Jr., Suskind RM, Blecker U. The health benefits of physical activity in children and adolescents: implications for chronic disease prevention. Eur J Pediatr 1999;158:271-274.
    34. Vandenplas Y, Blecker U. Helicobacter pylori infection in children. Acta Paediatrica 1998; 87:1105-1112.
    35. Mehta DI, Blecker U. Chronic diarrhea in infancy and childhood. J La State Med Soc 1998;150:419-429.
    36. Begue R, Mehta DI, Blecker U. Escherichia coli and the Hemolytic Uremic Syndrome: A Review. S Med J 1998;91:797-805.
    37. Lanciers S, Mehta DI, Blecker U, Lebenthal E. Modified food starches in baby foods. Ind J Pediatr 1998;65:509-514.    
    38. Hauser B, Blecker U, Keymolen K, Suys B, Gerlo E, Loeb H, Vandenplas Y. Plasma amino acid concentrations in term infants fed a whey predominant formula or a whey hydrolysate formula. JPEN 1997;21:27-30.
    39. Lanciers S, Mehta DI, Blecker U, Lebenthal E. The role of modified food starches in baby foods. J La State Med Soc 1997;149:211-214.
    40. Blecker U.The role of hydrolyzed formulas in nutritional allergy prevention in infants. S Med J 1997;90:1170-1175.
    41. Blecker U, Mehta DI.Diagnosis of Helicobacter pylori infection in children. Ind J Pediatr 1997;64:629-640.        
    42. Blecker U. Helicobacter pylori associated gastroduodenal pathology. S Med J  1997;90:569-577.
    43. Blecker U, Gold BD. Treatment of Helicobacter pylori infection: a review. Pediatr Inf   Dis J 1997;16:391-399.
    44. Blecker U, Vandenplas Y. Helicobacter pylori gastritis. Symptomen en diagnostiek/Gastrite à Helicobacter pylori. Symptomes et diagnostique. De agenda van de Specialist/L’agenda du Spécialiste 1996;6:12-13.
    45. Hauser B, Keymolen K, Vandenplas Y, Ramet J, Blecker U. Significant apnea and bradycardia in infants using cardiorespiratory home monitors with event recording. Int Pediatr 1996;11:271-274.
    46. Vandenplas Y, de Pont S, Vandemaele C, Troch E, Waterschoot S, Kaufman L, Blecker U. Dependability of oesophageal pH monitoring data on the software. J Pediatr Gastroenterol Nutr 1996;23:203-204.
    47. Blecker U, Hauser B, Lanciers S, Keymolen K, Vandenplas Y. Symptomatology of Helicobacter pylori infection in children. Acta Pædiatr 1996;85:1156-1158.
    48. Lanciers S, Mehta DI, Hauser B, Vandenplas Y, Blecker U. The prevalence of Helicobacter pylori positivity in asymptomatic children of different ethnic background living in the same country. Ethnicity  & Health 1996; 1:169-173.
    49. Vandenplas Y, Peeters S, Devreker T, Ramet J, Blecker U. Richtlijnen voor de behandeling van regurgitaties bij zuigelingen. Tijdschr Geneeskd 1996;52:533-535.
    50. Blecker U. Helicobacter pylori disease in childhood. Eur J Pediatr 1996;155:753-755.
    51. Blecker U, Mittal NK, Mehta DI. Presentation and management of Helicobacter pylori infections in children. Ind J Pediatr 1996;63:335-348.
    52. Blecker U, Vandenplas Y. Diagnosis of Helicobacter pylori infection in children. Int Pediatr 1996;11:78-83.
    53. Mehta DI, Lebenthal E, Blecker U. Chronic diarrhea in childhood: causes, presentation, and management. Ind J Pediatr1996;63:459-471.
    54. Mehta N, Mehta DI, Chone B, Kenge J, Gardi P, Khin-Maung-U, Blecker U. Role of Denver Developmental Screening Test in children in Gede, Kenya. Int Pediatr 1996;1:27-29.
    55. Blecker U. Helicobacter pylori disease in childhood. Clin Pediatr 1996;35:175-183.
    56. Blecker U, Vandenplas Y. Helicobacter pylori specific IgM antibodies in children born to infected mothers. J Pediatr Gastroenterol Nutr 1996;22:337-338.
    57. Blecker U, de Pont SMHB, Hauser B, Chouraqui JP, Gottrand F, Vandenplas Y. The role of "occult" gastroesophageal reflux in chronic pulmonary disease in children. Acta Gastroenterol Belg 1995;58:348-352.
    58. Blecker U, Lanciers S, Hauser B, de Pont S, Vandenplas Y. The contribution of specific IgM antibodies to the diagnosis of Helicobacter pylori infection in children. Eur J Gastroenterol Hepatol 1995;7:979-983.
    59. Blecker U, McKeithan TW, Hart J, Kirschner BS. Resolution of Helicobacter pylori-associated gastric lymphoproliferative disease in a child.Gastroenterology1995;109:973-977.
    60. Blecker U, Lanciers S, Hauser B, Vandenplas Y. Helicobacter pylori positivity in asymptomatic children of different ethnic groups living in the same country. S Afr Med J 1995;85:688.
    61. Blecker U, Mehta DI, Lanciers S, Dahodwala ID, Lebenthal E. Low incidence of Helicobacterpylori infection in children with recurrent abdominal complaints in Philadelphia. Pediatrics1995;95:618.
    62. Mehta DI, Hill ID, Singer-Granick C, Balloch Z, Blecker U. Primary sclerosing cholangitis and multiple autoimmune disorders in a patient with Down syndrome. Clin Pediatr1995;34:502-505.
    63. Vandenplas Y, Blecker U. Evaluation and complications of gastroesophageal reflux in infancy and childhood. Hepato Gastro 1995;2:227-236.
    64. Blecker U, Lanciers S, Hauser B, Vandenplas Y. Helicobacter pylori positivity in Belgium. Acta Gastroenterol Belg1995;58:31-34.
    65. Blecker U, Lanciers S, Hauser B, Mehta DI, Vandenplas Y. Serology as a valid screening test for Helicobacter pylori infection in asymptomatic subjects. Arch Pathol Laborator Med1995;119:30-32.
    66. Vandenplas Y, Blecker U, Heymans HSA. Gastro-oesofageale reflux bij zuigelingen: aanbevelingen voor diagnostiek en behandeling. Ned Tijdschr Geneeskd1995;139:366-370.
    67. Blecker U, Vandenplas Y.Therapeutische ontwikkelingen in de gastroënterologie / Dévelopments thérapeutiques en gastro-entérologie. De agenda van de Specialist / L’agenda duSpécialiste1995;4:2.
    68. Blecker U. Kindermishandeling/L'enfance maltraité. Roussel DIAGNOSE1994;294.
    69. Vandenplas Y, Ashkenazi A, Belli D, Blecker U, Boige N, Bouquet J, Cadranel S, Cezard JP, Cucchiara S, Dupont C, Geboes K, Gottrand F, Heymans HSA, Jasinski C, Kneepkens CMF, Milla P, Mougenot JF, Navarro J, Newell SJ, Nusslé D, Olafsdottir E, Peeters S, Polanco I, Ravelli A, Sandhu BK, Tolboom J. Reflux oesophagitis in infants and children. A report from the Working Group of the European Society of Paediatric Gastroenterology and Nutrition on gastro-oesophageal reflux disease. J Pediatr Gastroenterol Nutr1994;18:413-422.
    70. Suys B, De Wolf D, Hauser B, Blecker U, Vandenplas Y. Bradycardia and gastroesophageal reflux in term and preterm infants: is there any relation? J Pediatr Gastroenterol Nutr 1994;19:187-190.
    71. Blecker U, Lebenthal E. Endoscopic aspects of inflammatory bowel disease. Acta Endoscopica 1994;24:477-485.          
    72. Blecker U, Lanciers S, Vandenplas Y. The role of Helicobacter pylori in children with recurrent abdominal pain: The Brussels experience. Int Pediatr1994;9:276-279.
    73. Mehta DI, Lebenthal E, Blecker U.New strategies for the use of short polymers of glucose. Clin Pediatr1994;11:675-682.
    74. Vandenplas Y, Casteels A, Naert M, Derde MP, Blecker U. Abbreviated oesophageal pH monitoring in infants. Eur J Pediatr1994;153:80-83.
    75. Blecker U, Lanciers S, Vandenplas Y. Epidemiology of Helicobacter pylori infection in Belgium. Int Pediatr 1994;9:230-233.
    76. Blecker U, Keymolen K, Lanciers S, Bahwere P, Souayah H, Levy J, Vandenplas Y. The prevalence of Helicobacter pylori positivity in Human Immunodeficiency Virus infected children. J Pediatr Gastroenterol Nutr 1994;19:417-420.
    77. Blecker U, Lanciers S, Hauser B, Vandenplas Y. The prevalence of Helicobacter pylori in a symptom-free population, aged 1 to 40 years. J Clin Epidemiol1994;47:1095-1098.
    78. Blecker U, Lanciers S, Keppens E, Vandenplas Y. Evolution of Helicobacter pylori positivity in children born from positive mothers. J Pediatr Gastroenterol Nutr1994;19:87-90.
    79. Blecker U, Vandenplas Y. Verotoxin-producing Escherichia coli in "idiopathic"  thrombocytopenic purpura. Clin Pediatr1994;33:383.
    80. Blecker U, Lanciers S, Mehta DI, Vandenplas Y. Familial clustering of Helicobacter pylori infection. Clin Pediatr1994;33:307-308.
    81. Blecker U, Lanciers S, Mehta DI, Vandenplas Y. Manifestations of symptoms in children infected with Helicobacter pylori. J Pediatr Gastroenterol Nutr1994;18:406-407.
    82. Blecker U, Lanciers S, Mehta D.I, Vandenplas Y. Concordance between serology and 13C-urea breath test in the diagnosis of Helicobacter pylori infection. Am J Gastroenterol1994;89:459.
    83. Blecker U, De Meirleir L, De Raeve L, Ramet J, Vandenplas Y. Acrodermatitis-like syndrome in organic aciduria. Pediatrics1994; 93:537.
    84. Blecker U, Mehta DI, Vandenplas Y. Sex-ratio of Helicobacter pylori infection in childhood. AmJ Gastroenterol1994;89:293.
    85. Blecker U, Vandenplas Y. Usefulness of specific IgM in the diagnosis of Helicobacter pylori infection. Pediatrics1994;93:342-343.
    86. Blecker U, Hauser B, Vandenplas Y. "Hemoptysis" as an expression of Helicobacter pylori infection. J Pediatr Gastroenterol Nutr1994;18:116-117.
    87. Blecker U, Lanciers S, Lebenthal E, Vandenplas Y. Helicobacter pylori infection in neonates born from positive mothers. Am J Gastroenterol 1994;89:139-140.
    88. Blecker U, Fannes F, Vandenplas Y. Prevalentie van Helicobacter pylori bij asymptomatische kinderen. Mini Acta Paediatrica1993;24:29-31.
    89. Peeters S, Blecker U, Vandenplas Y. Vergelijking van diverse diagnostische technieken ivm. Helicobacter pylori gastritis. Mini Acta Paediatrica 1993;24:27-28.
    90. Blecker U, Vandenplas Y. De ureum breath test voor de opsporing van Helicobacter pylori. Mini Acta Paediatrica1993;25:119-121.
    91. Blecker U, Lanciers S, Hauser B. Validation of a new serologic test for the detection of Helicobacter pylori. Acta GastroenterolBelg1993;56:309-314.
    92. Blecker U, Lanciers S, Hauser B, Bougatef A, Debacker A, Vandenplas Y. "Congenital" hypertrophic pyloric stenosis, an acquired condition? J Pediatr Surg1993;28:1521.
    93. Blecker U, Vandenplas Y. Appearance of symptoms in Helicobacter pylori positive children.Eur J Gastroenterol Hepatol 1993;5:761.
    94. Blecker U, Richez M, Vandenplas Y. Haemoptysie als uiting van een Helicobacter pylori infektie. Tijdschr Kindergeneeskd 1993;61:185-187.
    95. Blecker U, Vandenplas Y. Serological diagnosis of Helicobacter pylori (letter). Gut 1993;34:1467.
    96. Blecker U, Vandenplas Y. Helicobacter pylori positivity. Eur J Pediatr 1993;152:863-864.
    97. Blecker U, Keymolen K, Levy J, Vandenplas Y. Low prevalence of Helicobacter pylori in the acquired immunodeficiency syndrome (letter). Am J Gastroenterol 1993;88:1294.
    98. Blecker U, Lanciers S, Hauser B, Suys B, van Roosbroeck A, Fannes F, Vandenplas Y. Positive and negative titres of a new serologic test for the detection of Helicobacter pylori. Eur J Gastroenterol Hepatol 1993;5:631-634.
    99. Blecker U, Vandenplas Y. Positive serology for Helicobacter pylori. Eur J Gastroenterol Hepatol 1993;5:665-666.
    100. Blecker U, Vandenplas Y. Helicobacter pylori infection in children. J Pediatr Gastroenterol Nutr 1993;17:117-118.
    101. Blecker U, Lanciers S, Hauser B, Vandenplas Y. Diagnosis of Helicobacter pylori infection in adults and children by using MALAKITTM HELICOBACTER PYLORI, a commercially available enzyme-linked immunosorbent assay. J Clin Microbiol1993; 31:1770-1773.
    102. Blecker U, Keymolen K, Souayah H, Levy J,Vandenplas Y.Helicobacter pylori in children with acquired immunodeficiency syndrome (letter).Pediatrics1993;91:1217.
    103. Blecker U, Hauser B, Lanciers S, Peeters S, Suys B, Fannes F, Vandenplas Y.The prevalence of Helicobacter pylori positive serology in asymptomatic children. J Pediatr Gastroenterology Nutr 1993; 16:252-256.
    104. Becker U,Vandenplas Y. Amoxicillin plus colloidal bismuth subcitrate, still an effectivetreatment against Helicobacter pylori infection in children (letter). Eur J Gastroenterol Hepatol1993; 5:397-398.
    105. Blecker U, Vandenplas Y. Ethnic differences in Helicobacter pylori infection (letter). Eur JPediatr 1993;152:377-378.
    106. Blecker U, Vandenplas Y. Helicobacter pylori serology (letter). J Clin Microbiol 1993; 31:173.
    107. Blecker U, Van Hauthem H, Lanciers S, Peeters S, Vandenplas Y. The effect of different feeds onthe incidence of postcibal gastro-oesophageal reflux in infants as measured by oesophageal pH monitoring. Eur J Gastroenterol Hepatol 1993; 5:47-50.
    108. Blecker U, Vandenplas Y. Ethnic differences in Helicobacter pylori infection (letter). Eur JPediatr 1993;152:176.
    109. Vandenplas Y, Blecker U, Lanciers S, Vandevelde A, De Backer A, Beyens T, Deconinck P. Fermeture endoscopique d'une fistule trachéo-oesophagienne récurrente. Ann Chir 1993;47:736-739.
    110. Hauser B, Keymolen K, Blecker U, Suys B, Bougatef A, Loeb H, Vandenplas Y. A comparative evaluation of whey hydrolysate and whey-predominant formulas. How well do infants tolerate them? Clin Pediatr1993; 32:433-437.
    111. Vandenplas Y, Hauser B, Blecker U, Suys B, Peeters S, Keymolen K, Loeb H. The nutritional value of a whey hydrolysate formula compared to a whey predominant formula in healthy infants. J Pediatr Gastroenterol Nutr1993; 17:92-96.
    112. Peeters S, Blecker U, De Valck J, Goossens A, Hautekeete M, Devis G, Vandenplas Y. Asymptomatic autoimmune chronic active hepatitis in a male adolescent. Eur J Pediatr 1993;152:107-109.
    113. Goossens A, Lauwers S.Contribution of the 13C-urea breath test to the   detection of Helicobacter pylori gastritis in children. Pediatrics 1992;90:608-611.
    114. Vandenplas Y, Blecker U, Devreker T, Keppens E, Nijs J, Cadranel S, Pipeleers-Marichal M,
    115. Blecker U, Vandenplas Y. Helicobacter pylori seropositivity in symptom-free children (letter). Lancet 1992; 8808(339):1537.
    116. Blecker U, Lanciers S, Peeters S, Vandenplas Y. Helicobacter pylori infekties bij kinderen. Tijdschr Kindergeneeskd 1992;60:35-39.
    117. Esophagitis of likely traumatic origin in newborns. J Pediatr Gastroenterology Nutr 1992; 15:81-84.
    118. Deneyer M,Goossens A, Pipeleers-Marichal M, Hauser B, Blecker U, Sacré L, VandenplasY.
    119. Vandenplas Y, Diericx A, Blecker U, Lanciers S, Deneyer M. Esophageal pH monitoring data during chest physiotherapy. J Pediatr Gastroenterol Nutr 1991; 13:23-26.
    120. Blecker U Renders F, Lanciers S, Vandenplas Y.Syncopes leading to the diagnosis of a Helicobacter pylori positive chronic active haemorrhagic gastritis. Eur J Pediatr 1991; 150: 560-561.

     

     

    Heart Health Journal Flyer